The University of Chicago Header Logo

Search Results (10)

More Search Options
MatchTypeWhy
MUC4 expression by immunohistochemistry is a specific marker for BCR-ABL1+ and BCR-ABL1-like B-lymphoblastic leukemia.Academic Article Why?
Chronic myelogenous leukemia, BCR-ABL1+.Academic Article Why?
MLL Rearrangment and EVI1 Deletion in BCR/ABL1 Positive Chronic Myeloid Leukemia.Academic Article Why?
Detection and quantification of BCR-ABL1 fusion transcripts by droplet digital PCR.Academic Article Why?
Template for Reporting Results of Monitoring Tests for Patients With Chronic Myelogenous Leukemia (BCR-ABL1(+)).Academic Article Why?
BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia.Academic Article Why?
BCR-ABL1-like B-Lymphoblastic Leukemia/Lymphoma with FOXP1-ABL1 Rearrangement: Comprehensive Laboratory Identification Allowing Tyrosine Kinase Inhibitor Use.Academic Article Why?
Cytogenetic, fluorescence in situ hybridization, and genomic array characterization of chronic myeloid leukemia with cryptic BCR-ABL1 fusions.Academic Article Why?
Involvement of Rho-Associated Coiled-Coil Containing Kinase (ROCK) in BCR-ABL1 Tyrosine Kinase Inhibitor Cardiovascular Toxicity.Academic Article Why?
Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group.Academic Article Why?
Per Page    Page  of 1
Next
Prev
Search Criteria
  • B
  • BCR
  • ABL1
  • like
Filter by Type
_
Click "Why?" to see why an item matched the search.